Annual Cash & Cash Equivalents
$5.86 M
-$21.14 M-78.29%
December 31, 2023
Summary
- As of February 8, 2025, RANI annual cash & cash equivalents is $5.86 million, with the most recent change of -$21.14 million (-78.29%) on December 31, 2023.
- During the last 3 years, RANI annual cash & cash equivalents has fallen by -$67.19 million (-91.97%).
- RANI annual cash & cash equivalents is now -95.01% below its all-time high of $117.45 million, reached on December 31, 2021.
Performance
RANI Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$4.28 M
-$237.00 K-5.25%
September 30, 2024
Summary
- As of February 8, 2025, RANI quarterly cash and cash equivalents is $4.28 million, with the most recent change of -$237.00 thousand (-5.25%) on September 30, 2024.
- Over the past year, RANI quarterly cash and cash equivalents has dropped by -$237.00 thousand (-5.25%).
- RANI quarterly cash and cash equivalents is now -96.70% below its all-time high of $129.74 million, reached on September 30, 2021.
Performance
RANI Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RANI Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -78.3% | -5.3% |
| 3 y3 years | -92.0% | -5.3% |
| 5 y5 years | -64.5% | -5.3% |
RANI Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -95.0% | at low | -96.4% | at low |
| 5 y | 5-year | -95.0% | at low | -96.7% | at low |
| alltime | all time | -95.0% | at low | -96.7% | at low |
Rani Therapeutics Holdings Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.28 M(-5.3%) |
| Jun 2024 | - | $4.51 M(-34.4%) |
| Mar 2024 | - | $6.88 M(+17.3%) |
| Dec 2023 | $5.86 M(-78.3%) | $5.86 M(+17.9%) |
| Sep 2023 | - | $4.97 M(-34.2%) |
| Jun 2023 | - | $7.55 M(-60.2%) |
| Mar 2023 | - | $18.98 M(-29.7%) |
| Dec 2022 | $27.01 M | $27.01 M(-0.8%) |
| Sep 2022 | - | $27.22 M(-72.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $97.18 M(-9.9%) |
| Mar 2022 | - | $107.84 M(-8.2%) |
| Dec 2021 | $117.45 M(+60.8%) | $117.45 M(-9.5%) |
| Sep 2021 | - | $129.74 M(+87.2%) |
| Jun 2021 | - | $69.31 M(-9.6%) |
| Mar 2021 | - | $76.66 M(+4.9%) |
| Dec 2020 | $73.06 M(+341.8%) | $73.06 M(+169.7%) |
| Sep 2020 | - | $27.09 M(+26.9%) |
| Jun 2020 | - | $21.35 M |
| Dec 2019 | $16.54 M | - |
FAQ
- What is Rani Therapeutics Holdings annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings annual cash & cash equivalents year-on-year change?
- What is Rani Therapeutics Holdings quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Rani Therapeutics Holdings?
- What is Rani Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
What is Rani Therapeutics Holdings annual cash & cash equivalents?
The current annual cash & cash equivalents of RANI is $5.86 M
What is the all time high annual cash & cash equivalents for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high annual cash & cash equivalents is $117.45 M
What is Rani Therapeutics Holdings annual cash & cash equivalents year-on-year change?
Over the past year, RANI annual cash & cash equivalents has changed by -$21.14 M (-78.29%)
What is Rani Therapeutics Holdings quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RANI is $4.28 M
What is the all time high quarterly cash and cash equivalents for Rani Therapeutics Holdings?
Rani Therapeutics Holdings all-time high quarterly cash and cash equivalents is $129.74 M
What is Rani Therapeutics Holdings quarterly cash and cash equivalents year-on-year change?
Over the past year, RANI quarterly cash and cash equivalents has changed by -$237.00 K (-5.25%)